Software-As-A-Service for improving Drug Research towards a standardized approach
Publish Year: 1395
نوع سند: مقاله ژورنالی
زبان: English
View: 303
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ACSIJ-5-1_011
تاریخ نمایه سازی: 19 آبان 1397
Abstract:
Software as a Service (SaaS) is one of the most interesting applications of a service-oriented architecture. SaaS spares users the cost of acquiring and maintaining hardware and software. The SaaS business model is very widely appreciated in the economy, because it brings not only financial benefits but also process-optimizing benefits. Drug research is a lengthy, complex and costly process that involves a number of disciplines, from medicine through economics to natural science. Until recently, the standard programs and infrastructure used for data analysis were almost exclusively commercial, proprietary, closed source and expensive. One of the major attractions of the open-source model is to customize the platform to suite the requirements and react faster on changes. There are different proprietary approaches. However there is a gap in knowledge regarding using closed and proprietary infrastructure. The aim of this research is to investigate the impact of an open source SaaS approach on the drug research process.
Keywords:
Authors
Keis Husein
London School of Commerce, Associate College of Cardiff Metropolitan University, London SE۱ ۱NX, United Kingdom
Ezendu Ariwa
Department of Computer Science and Technology, University of Bedfordshire Luton, LU۱ ۳JU, United Kingdom
Paul Bocij
Aston Business School, Aston University Birmingham, B۴ ۷ET, United Kingdom